Avalere’s Insights on Rare Disease
Summary
In this installment of our 2024 Trends Influencing Rare Disease series, Avalere experts summarize key learnings for pharmaceutical companies to consider.Webinar | 2026 Part D Plan and Manufacturer Contracting Strategies
On Wednesday, October 30, at 1 PM ET, join our webinar to learn how Part D redesign and drug price negotiation will shape the Plan Year 2026 market, and what this means for manufacturers and plans.
Services
From beginning to end, our team synergy
produces measurable results. Let's work together.
produces measurable results. Let's work together.
